Login / Signup

Prognosis and Novel Drug Targets for Key lncRNAs of Epigenetic Modification in Colorectal Cancer.

Peng ZhangTingting ZhangDenggang ChenLi GongBin Xiong
Published in: Mediators of inflammation (2023)
The research may give new perspectives on tailored therapy approaches as well as novel theories for forecasting the prognosis of CRC patients.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • ejection fraction
  • newly diagnosed
  • gene expression
  • stem cells
  • emergency department
  • mesenchymal stem cells
  • network analysis
  • adverse drug
  • patient reported